Cargando…
Acute Myeloid Leukemia in Infants: Biology and Treatment
Children aged 0–2 years (i.e., infants) with acute myeloid leukemia (AML) are a peculiar subgroup of patients in the childhood AML scenario. They present with distinctive biological and clinical characteristics, including a high prevalence of prognostically unfavorable risk factors and an increased...
Autores principales: | Masetti, Riccardo, Vendemini, Francesca, Zama, Daniele, Biagi, Carlotta, Pession, Andrea, Locatelli, Franco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4411976/ https://www.ncbi.nlm.nih.gov/pubmed/25973412 http://dx.doi.org/10.3389/fped.2015.00037 |
Ejemplares similares
-
Editorial: New Perspectives on Pediatric Acute Leukemia
por: Masetti, Riccardo, et al.
Publicado: (2020) -
The Role of HDACs Inhibitors in Childhood and Adolescence Acute
Leukemias
por: Masetti, Riccardo, et al.
Publicado: (2011) -
Identification of the NUP98-PHF23 fusion gene in pediatric cytogenetically normal acute myeloid leukemia by whole-transcriptome sequencing
por: Togni, Marco, et al.
Publicado: (2015) -
Impact of Inflammatory Cytokine Gene Polymorphisms on Developing Acute Graft-versus-Host Disease in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
por: Masetti, Riccardo, et al.
Publicado: (2015) -
Central Nervous System Complications in Children Receiving Chemotherapy or Hematopoietic Stem Cell Transplantation
por: Cordelli, Duccio Maria, et al.
Publicado: (2017)